AIM ImmunoTech (AIM) Cash Flow Statement

Click line-items for a historical chart and %

Net (loss) income	-413K
Depreciation	120K
Amortization	4K
Accretion on long-term debt
Loss on early extinguishment of debt
Recovery of previously written off bad debts
Provision for bad debts	31K
Provision for obsolete and slow-moving inventory	23K
Provision for warranty	0
Provision for contract losses	0
Stock-based compensation	56K
Gain from casualty
Proceeds from insurance
(Benefit) provision for deferred income taxes	-243K
Accounts receivable, net	1.83M
Inventories, net	36K
Prepaid expenses and other current assets, net	-313K
Accounts payable, trade	285K
Customer advances
Compensation and benefits	-283K
Income taxes payable
Accrued expenses and other liabilities	41K
Net cash provided by (used in) operating activities	974K
Capital expenditures	-202K
Net cash used in investing activities	-202K
Net increase in revolving credit facility	-550K
Principal payments on notes payable
Proceeds from issuance of notes payable
Principal payments on long-term debt	-254K
Proceeds from refinancing of long-term debt
Net cash provided by financing activities	-772K
Change in cash and cash equivalents	0
Cash and cash equivalents, beginning of period	0
Cash and cash equivalents, end of period	0
Interest	59K
Income taxes	65K
Common stock warrants issued

Entities mentioned with AIM

View All Entities